Site search
2900 results for '' found
Inter-organ cross talk in heart failure: A multisite biomarker sampling study (ACTRN12621001725853)
Inter-organ cross talk in heart failure: A multisite biomarker sampling study (ACTRN12621001725853)
/
mavaCamten Observational evidence Global cOnsortium in HCM [COLLIGO-HCM] (NCT06372457)
mavaCamten Observational evidence Global cOnsortium in HCM [COLLIGO-HCM] (NCT06372457)
/
A Prospective, Screening Study of Bleeding and Treatment in Participants with Von Willebrand Disease
A Prospective, Screening Study of Bleeding and Treatment in Participants with Von Willebrand Disease
/
A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer (NCT06012435)
A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer (NCT06012435)
/
PRotecting cerebral injury and IMproving outcomEs with SGLT2 inhibitors in comatose Out-Of-Hospital Cardiac Arrest survivors – a Pilot Study (ACTRN12624001183572)
PRotecting cerebral injury and IMproving outcomEs with SGLT2 inhibitors in comatose Out-Of-Hospital Cardiac Arrest survivors – a Pilot Study (ACTRN12624001183572)
/
GuiDIng energy provision using indiREct CalorimeTry: a pilot feasibility randomised controlled trial in critically ill adults with obesity [DIRECT Trial] (NCT06053216)
GuiDIng energy provision using indiREct CalorimeTry: a pilot feasibility randomised controlled trial in critically ill adults with obesity [DIRECT Trial] (NCT06053216)
/
A multi-centre, Australian and New Zealand, phase II exploratory study of amendments to conditioning regimens in haplo-identical stem cell transplantation (ANZHIT-2) (ACTRN12622001232729)
A multi-centre, Australian and New Zealand, phase II exploratory study of amendments to conditioning regimens in haplo-identical stem cell transplantation (ANZHIT-2) (ACTRN12622001232729)
/
ASCENDANCE - ASCiminib Evaluation in Newly diagnosed CML with Dasatinib to Augment response in Complex genomic Etiology (ACTRN12623001338651)
ASCENDANCE - ASCiminib Evaluation in Newly diagnosed CML with Dasatinib to Augment response in Complex genomic Etiology (ACTRN12623001338651)
/
Portico NG - Evaluation of the Navitor Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
Portico NG - Evaluation of the Navitor Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
/
A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve
A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve
/